Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Investors Bet Billions On Big Biopharma Offerings

May 29 2020

• By Mandy Jackson

Finance Watch

Related Content

FDA Approval Round Up: Keytruda, Opdivo Add Claims

Sep 25 2017

Four Early-Stage Antibacterial Drugs To Watch: Highlights From IDWeek

Oct 09 2018

IPOs In Review: Biopharma Offerings Bounced Back In 2017 As Returns Rose

Jan 04 2018

CF Foundation's $3.3bn royalty sale will fund drugs, services

Nov 21 2014

Opening The Door For Cell Therapy In Solid Tumors

Sep 10 2019

Finance Watch: As US IPO Market Gets More Challenging, Two Companies Opt Out

Nov 13 2019

Finance Watch: Two New Funds Provide $1.4bn For Health Care Ventures

Nov 22 2019

Finance Watch: Billions Flow Into Biopharma Via Three New Investment Funds

Jan 11 2020

Investors Wake Up To Success Of Idorsia Sleep Drug

Apr 20 2020

Finance Watch: ORIC Raises $120m In Another Pandemic Era Biopharma IPO

Apr 25 2020

Finance Watch: iTeos, Pandion And Aspen Show COVID-19 Hasn’t Slowed VC Deals Yet

Apr 01 2020

Coronavirus Update: Sanofi And GSK Unveil 'Unprecedented' Vaccine Alliance

Apr 14 2020

Finance Watch: Multiple VC Mega-Rounds Fund T-Cell, Hearing, IO, Fibrosis Therapies

Mar 07 2020

Finance Watch: Moderna Capitalizes On COVID-19 Vaccine Data Value Boost

May 20 2020

‘Friendly Breakup’: Sanofi And Regeneron Agree Equity Revamp

May 26 2020

Coronavirus Update: WHO Suspends Hydroxychloroquine Trial, Novavax Launches Phase I/II Vaccine Study

May 26 2020

Finance Watch: Ayala Launches First Biopharma IPO In May

May 09 2020

ASCO 2020: BCMA CAR-T Race Heats Up Between Bristol And Janssen

May 14 2020

Coronavirus Update: Novavax's $384m Is CEPI’s Biggest Vaccine Funding

May 12 2020

Iovance TIL Appeal Seen Luring Potential Buyers

Feb 26 2020

Oyster Point Looks To Compete In Dry Eye With Nasal Spray Therapeutic

Jul 12 2018

Geron Has Cash, But Does It Have The Imetelstat Data To Push On Without Janssen?

Sep 27 2018

Arena Ready For Etrasimod Phase III Face-Off With Celgene's Ozanimod In UC

Mar 20 2018

BioNotebook: Denovo, Celimmune revive Lilly, Amgen programs; Malin invests in Serenus; J&J opens fourth incubator; Blueprint, Alexion partner

Mar 04 2015

Flexion's Zilretta Poised For Market Of Diabetics With Knee Pain

Oct 09 2017

IPO Update: 35 Biopharmas Provide -6.1% Average Return; New Offerings Feel Stock Market Impact

Oct 03 2019

Mersana Axes Lead ADC Compound, Puts All Its Eggs In NaPi2b Basket

Jan 07 2019

Finance Watch: Forma Raises $100m In Quest To Become A Sickle Cell Leader

Dec 20 2019

AstraZeneca Likes Sound Of Silence's Science

Mar 25 2020

Related Companies

Moderna, Inc.

argenx N.V.

Sanofi

Regeneron Pharmaceuticals, Inc.

Iovance Biotherapeutics, Inc.

Idorsia Pharmaceuticals Ltd

Arcus Biosciences, Inc.

Gilead Sciences, Inc.

Arena Pharmaceuticals, Inc.

Novavax, Inc.

Atara Biotherapeutics, Inc.

Mersana Therapeutics, Inc.

Viela Bio, Inc.

Geron Corporation

Oyster Point Pharma, Inc.

BioCryst Pharmaceuticals, Inc.

Flexion Therapeutics, Inc.

ContraFect Corporation

Pfizer Inc.

VBI Vaccines Inc.

scPharmaceuticals, Inc.

Additional Topics

Financing Business Strategies Innovation Deals Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window